Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00318682
Other study ID # IC0504
Secondary ID
Status Terminated
Phase N/A
First received April 25, 2006
Last updated February 11, 2009
Start date May 2006
Est. completion date August 2008

Study information

Verified date September 2006
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

A new approach to the evaluation of liver fibrosis has been proposed using PULSOMETRY. The objective is to evaluate the diagnostic performances of the FIBROSCAN technique, together with non-invasive techniques, and to determine how it is able to predict the histological fibrosis score, defined by the METAVIR score. This transversal study aims to compare the evaluation of hepatic fibrosis obtained by FIBROSCAN and histology (METAVIR score) in 2550 consecutive patients taken in charge for a liver biopsy. The results of the study will compare the respective performances of these techniques in the prediction of the METAVIR score, and help in the recommendation of the care of patients with viral hepatitis B and C; these methods will undergo a medico-economic study.


Description:

Read more »
Read more »

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
FIBROSCAN
diagnostic examination of the hepato fibrosis

Locations

Country Name City State
France Hopital Beaujon Clichy
France Hopital Saint-Antoine Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

See also
  Status Clinical Trial Phase
Completed NCT00342186 - Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
Completed NCT00097006 - Retrovirus Epidemiology Donor Study-II (REDS-II) N/A
Completed NCT00007371 - Hepatitis C in Clinically Discordant Hemophilic Siblings N/A
Completed NCT00005305 - Hepatitis Delta Infections in Hemophiliacs N/A
Completed NCT00005304 - Delta Hepatitis and Liver Disease in Hemophiliacs
Completed NCT00000583 - Hepatitis B Vaccine Clinical Trial Phase 3
Completed NCT00000580 - Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin Phase 3
Recruiting NCT03776760 - Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination
Completed NCT00915057 - Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972. Phase 2
Completed NCT00564811 - Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) N/A
Completed NCT00005306 - Natural History of Post-transfusion Non-A, Non-B Hepatitis N/A
Completed NCT01804829 - Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Phase 3
Completed NCT01170741 - Computer-Assisted Tailored Cue-card Health [CATCH] Study Phase 1
Completed NCT01163240 - Epidemiological Study in Children and Adolescents With Chronic Hepatitis B N/A
Completed NCT00116454 - Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis Phase 3
Completed NCT00005309 - Prospective Study of HIV Infection in Hemophiliacs
Completed NCT00913757 - A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Completed NCT00608192 - HIV and Hepatitis Care Coordination in Methadone Treatment N/A
Enrolling by invitation NCT05492565 - Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Completed NCT00005339 - Risk of Post Transfusion Hepatitis C Virus Infection N/A